Build Your Comparison

Side-by-side financial analysis
FORA logo
FORA
CSGP logo
CSGP
Z logo
Z
INFU logo
INFU
JPM logo
JPM
Try popular comparisons:

Stock Comparison

FORA vs CSGP vs Z vs INFU vs JPM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FORA
Forian Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$68M
5Y Perf.-78.5%
CSGP
CoStar Group, Inc.

Real Estate - Services

Real EstateNASDAQ • US
Market Cap$12.77B
5Y Perf.-57.9%
Z
Zillow Group, Inc. Class C

Internet Content & Information

Communication ServicesNASDAQ • US
Market Cap$7.72B
5Y Perf.-65.8%
INFU
InfuSystem Holdings, Inc.

Medical - Instruments & Supplies

HealthcareAMEX • US
Market Cap$190M
5Y Perf.-50.2%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$908.57B
5Y Perf.+105.8%

FORA vs CSGP vs Z vs INFU vs JPM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FORA logoFORA
CSGP logoCSGP
Z logoZ
INFU logoINFU
JPM logoJPM
IndustryMedical - Healthcare Information ServicesReal Estate - ServicesInternet Content & InformationMedical - Instruments & SuppliesBanks - Diversified
Market Cap$68M$12.77B$7.72B$190M$908.57B
Revenue (TTM)$30M$3.41B$2.69B$142M$280.33B
Net Income (TTM)$-5M$25M$61M$8M$57.05B
Gross Margin46.8%77.4%73.3%56.7%60.0%
Operating Margin-13.4%-0.8%0.4%9.1%25.9%
Forward P/E22.1x14.1x22.2x14.6x
Total Debt$12K$1.14B$536M$3M$942.38B
Cash & Equiv.$13M$1.73B$773M$3M$343.34B

FORA vs CSGP vs Z vs INFU vs JPMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FORA
CSGP
Z
INFU
JPM
StockMar 21May 26Return
Forian Inc. (FORA)10021.5-78.5%
CoStar Group, Inc. (CSGP)10042.1-57.9%
Zillow Group, Inc. … (Z)10034.2-65.8%
InfuSystem Holdings… (INFU)10049.8-50.2%
JPMorgan Chase & Co. (JPM)100205.8+105.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: FORA vs CSGP vs Z vs INFU vs JPM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: FORA and INFU are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. InfuSystem Holdings, Inc. is the stronger pick specifically for recent price momentum and sentiment and operational efficiency and capital deployment. JPM and Z also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
FORA
Forian Inc.
The Income Pick

FORA has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.

  • beta 0.21
  • Rev growth 50.1%, EPS growth 23.0%, 3Y rev CAGR 22.6%
  • Lower volatility, beta 0.21, Low D/E 0.0%, current ratio 2.97x
  • Beta 0.21, current ratio 2.97x
Best for: income & stability and growth exposure
CSGP
CoStar Group, Inc.
The REIT Holding

Among these 5 stocks, CSGP doesn't own a clear edge in any measured category.

Best for: real estate exposure
Z
Zillow Group, Inc. Class C
The Value Play

Z is the clearest fit if your priority is value.

  • Lower P/E (14.1x vs 14.6x)
Best for: value
INFU
InfuSystem Holdings, Inc.
The Momentum Pick

INFU is the #2 pick in this set and the best alternative if momentum and efficiency is your priority.

  • +52.2% vs CSGP's -62.1%
  • 7.9% ROA vs FORA's -11.8%, ROIC 12.5% vs -7.5%
Best for: momentum and efficiency
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM ranks third and is worth considering specifically for long-term compounding.

  • 481.2% 10Y total return vs INFU's 240.1%
  • 20.4% margin vs FORA's -17.0%
  • 1.8% yield; 15-year raise streak; the other 4 pay no meaningful dividend
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthFORA logoFORA50.1% revenue growth vs JPM's 3.3%
ValueZ logoZLower P/E (14.1x vs 14.6x)
Quality / MarginsJPM logoJPM20.4% margin vs FORA's -17.0%
Stability / SafetyFORA logoFORABeta 0.21 vs INFU's 1.22, lower leverage
DividendsJPM logoJPM1.8% yield; 15-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)INFU logoINFU+52.2% vs CSGP's -62.1%
Efficiency (ROA)INFU logoINFU7.9% ROA vs FORA's -11.8%, ROIC 12.5% vs -7.5%

FORA vs CSGP vs Z vs INFU vs JPM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FORAForian Inc.
FY 2022
Information and Software
93.5%$26M
Service
5.5%$2M
Product and Service, Other
1.0%$274,256
CSGPCoStar Group, Inc.
FY 2024
CoStar Suite
61.1%$1.0B
LoopNet
16.9%$282M
Information services
8.1%$136M
Online Marketplaces
7.8%$130M
Residential
6.0%$101M
ZZillow Group, Inc. Class C
FY 2025
Sales Revenue
44.9%$1.9B
Residential Revenue
40.2%$1.7B
Rental Revenue
14.9%$630M
INFUInfuSystem Holdings, Inc.
FY 2025
Patient Services
57.4%$87M
Device Solutions
42.6%$64M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000

FORA vs CSGP vs Z vs INFU vs JPM — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLINFULAGGINGZ

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 3 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 9328.3x FORA's $30M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to FORA's -17.0%. On growth, CSGP holds the edge at +22.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFORA logoFORAForian Inc.CSGP logoCSGPCoStar Group, Inc.Z logoZZillow Group, Inc…INFU logoINFUInfuSystem Holdin…JPM logoJPMJPMorgan Chase & …
RevenueTrailing 12 months$30M$3.4B$2.7B$142M$280.3B
EBITDAEarnings before interest/tax-$4M$278M$221M$26M$81.4B
Net IncomeAfter-tax profit-$5M$25M$61M$8M$57.0B
Free Cash FlowCash after capex$2M$241M$431M$20M$100.9B
Gross MarginGross profit ÷ Revenue+46.8%+77.4%+73.3%+56.7%+60.0%
Operating MarginEBIT ÷ Revenue-13.4%-0.8%+0.4%+9.1%+25.9%
Net MarginNet income ÷ Revenue-17.0%+0.7%+2.3%+5.6%+20.4%
FCF MarginFCF ÷ Revenue+7.8%+7.1%+16.0%+14.3%+36.0%
Rev. Growth (YoY)Latest quarter vs prior year-2.9%+22.5%+18.4%-3.0%
EPS Growth (YoY)Latest quarter vs prior year-2.0%+127.7%+5.1%+5.9%+16.0%
JPM leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

INFU leads this category, winning 3 of 6 comparable metrics.

At 16.2x trailing earnings, JPM trades at a 99% valuation discount to CSGP's 1814.5x P/E. On an enterprise value basis, INFU's 7.5x EV/EBITDA is more attractive than CSGP's 71.6x.

MetricFORA logoFORAForian Inc.CSGP logoCSGPCoStar Group, Inc.Z logoZZillow Group, Inc…INFU logoINFUInfuSystem Holdin…JPM logoJPMJPMorgan Chase & …
Market CapShares × price$68M$12.8B$7.7B$190M$908.6B
Enterprise ValueMkt cap + debt − cash$55M$12.2B$7.5B$190M$1.51T
Trailing P/EPrice ÷ TTM EPS-23.48x1814.46x354.81x30.39x16.22x
Forward P/EPrice ÷ next-FY EPS est.22.11x14.10x22.16x14.60x
PEG RatioP/E ÷ EPS growth rate0.92x
EV / EBITDAEnterprise value multiple71.63x28.65x7.55x18.52x
Price / SalesMarket cap ÷ Revenue2.24x3.93x2.99x1.33x3.25x
Price / BookPrice ÷ Book value/share2.27x1.52x1.67x3.47x2.51x
Price / FCFMarket cap ÷ FCF23.49x311.35x32.83x7.97x9.01x
INFU leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

INFU leads this category, winning 5 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-17 for FORA. FORA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), INFU scores 8/9 vs JPM's 5/9, reflecting strong financial health.

MetricFORA logoFORAForian Inc.CSGP logoCSGPCoStar Group, Inc.Z logoZZillow Group, Inc…INFU logoINFUInfuSystem Holdin…JPM logoJPMJPMorgan Chase & …
ROE (TTM)Return on equity-17.2%+0.3%+1.3%+14.0%+15.9%
ROA (TTM)Return on assets-11.8%+0.2%+1.1%+7.9%+1.3%
ROICReturn on invested capital-7.5%-0.9%-0.5%+12.5%+4.5%
ROCEReturn on capital employed-8.2%-0.8%-0.6%+14.3%+8.9%
Piotroski ScoreFundamental quality 0–965785
Debt / EquityFinancial leverage0.00x0.14x0.11x0.06x2.60x
Net DebtTotal debt minus cash-$13M-$589M-$237M$241,000$599.0B
Cash & Equiv.Liquid assets$13M$1.7B$773M$3M$343.3B
Total DebtShort + long-term debt$12,137$1.1B$536M$3M$942.4B
Interest CoverageEBIT ÷ Interest expense-48.78x1.58x5.22x15.54x0.74x
INFU leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $1,735 for FORA. Over the past 12 months, INFU leads with a +52.2% total return vs CSGP's -62.1%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs CSGP's -29.3% — a key indicator of consistent wealth creation.

MetricFORA logoFORAForian Inc.CSGP logoCSGPCoStar Group, Inc.Z logoZZillow Group, Inc…INFU logoINFUInfuSystem Holdin…JPM logoJPMJPMorgan Chase & …
YTD ReturnYear-to-date+2.4%-54.1%-51.3%+12.3%+0.8%
1-Year ReturnPast 12 months+2.4%-62.1%-52.5%+52.2%+20.9%
3-Year ReturnCumulative with dividends-7.3%-64.7%-32.9%-7.6%+138.8%
5-Year ReturnCumulative with dividends-82.7%-65.7%-72.3%-50.2%+135.5%
10-Year ReturnCumulative with dividends-90.5%+43.4%-7.6%+240.1%+481.2%
CAGR (3Y)Annualised 3-year return-2.5%-29.3%-12.5%-2.6%+33.7%
JPM leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — FORA and JPM each lead in 1 of 2 comparable metrics.

FORA is the less volatile stock with a 0.21 beta — it tends to amplify market swings less than INFU's 1.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs CSGP's 30.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFORA logoFORAForian Inc.CSGP logoCSGPCoStar Group, Inc.Z logoZZillow Group, Inc…INFU logoINFUInfuSystem Holdin…JPM logoJPMJPMorgan Chase & …
Beta (5Y)Sensitivity to S&P 5000.21x0.45x1.15x1.22x0.87x
52-Week HighHighest price in past year$2.71$97.43$93.88$11.04$338.09
52-Week LowLowest price in past year$1.64$29.53$31.48$5.38$269.72
% of 52W HighCurrent price vs 52-week peak+80.1%+30.9%+34.2%+85.3%+96.2%
RSI (14)Momentum oscillator 0–10063.831.031.141.572.1
Avg Volume (50D)Average daily shares traded40K7.0M4.0M172K7.4M
Evenly matched — FORA and JPM each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: CSGP as "Buy", Z as "Hold", INFU as "Buy", JPM as "Buy". Consensus price targets imply 111.0% upside for Z (target: $68) vs 4.5% for JPM (target: $340). JPM is the only dividend payer here at 1.83% yield — a key consideration for income-focused portfolios.

MetricFORA logoFORAForian Inc.CSGP logoCSGPCoStar Group, Inc.Z logoZZillow Group, Inc…INFU logoINFUInfuSystem Holdin…JPM logoJPMJPMorgan Chase & …
Analyst RatingConsensus buy/hold/sellBuyHoldBuyBuy
Price TargetConsensus 12-month target$61.18$67.75$15.00$339.75
# AnalystsCovering analysts2546361
Dividend YieldAnnual dividend ÷ price+1.8%
Dividend StreakConsecutive years of raises15
Dividend / ShareAnnual DPS$5.95
Buyback YieldShare repurchases ÷ mkt cap+0.6%+4.5%+8.7%+5.8%+3.8%
Insufficient data to determine a leader in this category.
Key Takeaway

JPM leads in 2 of 6 categories (Income & Cash Flow, Total Returns). INFU leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.

Best OverallInfuSystem Holdings, Inc. (INFU)Leads 2 of 6 categories
Loading custom metrics...

FORA vs CSGP vs Z vs INFU vs JPM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is FORA or CSGP or Z or INFU or JPM a better buy right now?

For growth investors, Forian Inc.

(FORA) is the stronger pick with 50. 1% revenue growth year-over-year, versus 3. 3% for JPMorgan Chase & Co. (JPM). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 2x trailing P/E (14. 6x forward), making it the more compelling value choice. Analysts rate CoStar Group, Inc. (CSGP) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FORA or CSGP or Z or INFU or JPM?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 2x versus CoStar Group, Inc. at 1814. 5x. On forward P/E, Zillow Group, Inc. Class C is actually cheaper at 14. 1x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — FORA or CSGP or Z or INFU or JPM?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +135. 5%, compared to -82. 7% for Forian Inc. (FORA). Over 10 years, the gap is even starker: JPM returned +481. 2% versus FORA's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FORA or CSGP or Z or INFU or JPM?

By beta (market sensitivity over 5 years), Forian Inc.

(FORA) is the lower-risk stock at 0. 21β versus InfuSystem Holdings, Inc. 's 1. 22β — meaning INFU is approximately 480% more volatile than FORA relative to the S&P 500. On balance sheet safety, Forian Inc. (FORA) carries a lower debt/equity ratio of 0% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — FORA or CSGP or Z or INFU or JPM?

By revenue growth (latest reported year), Forian Inc.

(FORA) is pulling ahead at 50. 1% versus 3. 3% for JPMorgan Chase & Co. (JPM). On earnings-per-share growth, the picture is similar: InfuSystem Holdings, Inc. grew EPS 181. 8% year-over-year, compared to -95. 1% for CoStar Group, Inc.. Over a 3-year CAGR, FORA leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FORA or CSGP or Z or INFU or JPM?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -9. 5% for Forian Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -8. 2% for FORA. At the gross margin level — before operating expenses — CSGP leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is FORA or CSGP or Z or INFU or JPM more undervalued right now?

On forward earnings alone, Zillow Group, Inc.

Class C (Z) trades at 14. 1x forward P/E versus 22. 2x for InfuSystem Holdings, Inc. — 8. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for Z: 111. 0% to $67. 75.

08

Which pays a better dividend — FORA or CSGP or Z or INFU or JPM?

In this comparison, JPM (1.

8% yield) pays a dividend. FORA, CSGP, Z, INFU do not pay a meaningful dividend and should not be held primarily for income.

09

Is FORA or CSGP or Z or INFU or JPM better for a retirement portfolio?

For long-horizon retirement investors, JPMorgan Chase & Co.

(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 1. 8% yield, +481. 2% 10Y return). Both have compounded well over 10 years (JPM: +481. 2%, Z: -7. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between FORA and CSGP and Z and INFU and JPM?

These companies operate in different sectors (FORA (Healthcare) and CSGP (Real Estate) and Z (Communication Services) and INFU (Healthcare) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FORA is a small-cap high-growth stock; CSGP is a mid-cap high-growth stock; Z is a small-cap high-growth stock; INFU is a small-cap quality compounder stock; JPM is a large-cap deep-value stock. JPM pays a dividend while FORA, CSGP, Z, INFU do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.